Cite
Adjuvant Therapy in Resected Nonmetastatic Stage II–IV Gallbladder Cancer: A Generalized Propensity Score Analysis.
MLA
Wan, Wenze, et al. “Adjuvant Therapy in Resected Nonmetastatic Stage II–IV Gallbladder Cancer: A Generalized Propensity Score Analysis.” Oncology Research & Treatment, vol. 44, no. 7–8, July 2021, pp. 390–99. EBSCOhost, https://doi.org/10.1159/000517113.
APA
Wan, W., Zheng, B., Sun, W., Wang, J., Shen, S., Huang, L., Liu, H., Ni, X., & Liu, H. (2021). Adjuvant Therapy in Resected Nonmetastatic Stage II–IV Gallbladder Cancer: A Generalized Propensity Score Analysis. Oncology Research & Treatment, 44(7–8), 390–399. https://doi.org/10.1159/000517113
Chicago
Wan, Wenze, Bohao Zheng, Wentao Sun, Jiwen Wang, Sheng Shen, Lihong Huang, Han Liu, Xiaojian Ni, and Houbao Liu. 2021. “Adjuvant Therapy in Resected Nonmetastatic Stage II–IV Gallbladder Cancer: A Generalized Propensity Score Analysis.” Oncology Research & Treatment 44 (7–8): 390–99. doi:10.1159/000517113.